Status:

NOT_YET_RECRUITING

OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa

Lead Sponsor:

Yale University

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Malaria

Hiv

Eligibility:

All Genders

5-17 years

Phase:

PHASE4

Brief Summary

A longitudinal study with four parallel cohorts with each participant followed for 2 years: two cohorts in Busia (high malaria transmission site) and two cohorts in Kampala (low malaria transmission)....

Detailed Description

CLHIV will be maintained on a dolutegravir (DTG) based regimen for \>2 weeks prior to enrolment to ensure steady state. All children in Busia (HIV-infected and HIV-uninfected) will be enrolled and the...

Eligibility Criteria

Inclusion

  • Agreement to come to the clinic for all follow-up evaluations
  • Provision of informed consent and assent (as appropriate)
  • Residency within approximately 30 km of the study clinic
  • Negative blood smear for malaria (all sites)
  • For Children and adolescents living with HIV
  • Confirmed HIV infection
  • On DTG-based regimen for ≥14 days
  • For HIV-uninfected children - documentation of HIV-negative status by at least 1 assay

Exclusion

  • Significant comorbidities such as malignancy, active TB, chronic/active hepatitis B/C, diabetes, severe acute malnutrition, mitochondrial disorders
  • Receipt of known CYP interacting drugs at enrolment (except HAART) - see list of disallowed medications
  • Anemia defined by hemocue (Hb \< 7.0) at the time of enrolment
  • Signs of uncomplicated or severe malaria at the time of enrollment
  • Prior intolerance to AL or AS-AQ (for those in Busia only)
  • Pregnancy at enrolment (testing done at enrollment for all those of child-bearing age)
  • Concurrent enrolment in another research study

Key Trial Info

Start Date :

December 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

380 Patients enrolled

Trial Details

Trial ID

NCT06967519

Start Date

December 1 2025

End Date

December 1 2027

Last Update

October 30 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Baylor- Uganda

Kampala, Uganda

2

Infectious Disease Research Collaboration (IDRC)

Kampala, Uganda

OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa | DecenTrialz